926028-74-2 Usage
Uses
Used in Pharmaceutical Synthesis:
1H-Pyrrolo[2,3-c]pyridine, 5-(1-piperazinyl)is used as a building block for the synthesis of pharmaceuticals due to its heterocyclic structure and the presence of a pyrrolopyridine ring system and a piperazine group. These features allow it to be a versatile component in the creation of new medicinal compounds.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1H-Pyrrolo[2,3-c]pyridine, 5-(1-piperazinyl)is used as a subject of research for its potential pharmacological applications. Its unique structure positions it as a candidate for further exploration into its interactions with receptors in the central nervous system and other biological activities.
Used in the Development of Receptor Ligands:
1H-Pyrrolo[2,3-c]pyridine, 5-(1-piperazinyl)is utilized in the development of receptor ligands for the central nervous system. Its potential role as a ligand makes it a valuable compound for designing new drugs that can modulate receptor activity, which may lead to treatments for various neurological conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 926028-74-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,0,2 and 8 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 926028-74:
(8*9)+(7*2)+(6*6)+(5*0)+(4*2)+(3*8)+(2*7)+(1*4)=172
172 % 10 = 2
So 926028-74-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N4/c1-2-13-10-8-14-11(7-9(1)10)15-5-3-12-4-6-15/h1-2,7-8,12-13H,3-6H2
926028-74-2Relevant academic research and scientific papers
NOVEL 2,3-DIHYDROINDOLE COMPOUNDS
-
Page/Page column 21, (2010/11/26)
The invention relates to compounds of the formula I, wherein the variables are as defined in the claims. The compounds are useful in the treatment of a disease where a D4 receptor and/or a 5-HT2A receptor is implicated.
NOVEL 2,3-DIHYDROINDOLE COMPOUNDS
-
Page/Page column 8, (2008/06/13)
The invention relates to compounds of the formula I wherein the variables are as defined in the claims. The compounds are useful in the treatment of a disease where a D4 receptor and/or a 5-HT 2A receptor is implicated.
